ATMA CENA
All articles

Industry

34 articles

Two hands reaching toward each other over rocks by the sea in black and white, evoking reaching out for help and recovery.
Industry

Treating the Disease or Opening a Learning Window? What a New Review of Psychedelics for Substance Use Disorders Means for Canadian Practitioners

A new Yale and WashU review asks whether psychedelics treat substance use disorders or open a window for learning. What it means for Canadian practitioners.

A backlit profile silhouette with a fine mist in the air, evoking intranasal administration of a short-acting psychedelic.
Industry

One Nasal Dose, Two Hours in Clinic: What the New JAMA Mebufotenin Trial Means for Canadian Practitioners

A JAMA phase 2b trial links one intranasal dose of mebufotenin (5-MeO-DMT) to lower depression scores in TRD. What it means for Canadian clinicians.

Two therapists sit with a reclining patient in a quiet clinical room during a supervised psychedelic-assisted therapy session.
Industry

Israel Launches a National MDMA and Psilocybin Trial for PTSD. Here Is What Canadian Practitioners Can Take From It

Israel's Health Ministry announced a national trial of MDMA- and psilocybin-assisted therapy for chronic PTSD. What the protocol means for Canadian practitioners.

A calm therapy room with a green armchair and a leafy plant by frosted-glass windows, evoking a quiet integration conversation.
Industry

'The Start of a Process, Not the Cure': What Psychedelic Trial Participants Want Practitioners to Know

A new Frontiers in Psychiatry study asked former psychedelic trial participants what helped and what hurt. Key lessons for Canadian practitioners.

A calm clinical consultation room with two chairs and soft natural light, evoking supervised psilocybin-assisted therapy in a trial setting.
Industry

One Dose of Psilocybin, One Year of Follow-Up: What a Swedish Trial Tells Practitioners About Durability

A Swedish randomized trial followed single-dose psilocybin for depression for a full year. Rapid gains, then a fading edge. What it means for practitioners.

Therapist, support facilitator and patient in a calm clinical room, illustrating the two-provider session model proposed under New Mexico's medical psilocybin rules.
Training

New Mexico's Draft Psilocybin Rules Spell Out Who Can Deliver Care. Here Is What Canadian Practitioners Can Learn

New Mexico's draft medical psilocybin rules define three provider roles, training hours and session staffing. What the model means for Canadian clinicians.

A nurse reviews a heart-rhythm tracing on a tablet beside a patient in a quiet clinical room.
Industry

The FDA Just Described What a Safe Ibogaine Trial Would Require. Here Is What Practitioners Can Learn From It

The FDA wants input on how to run ibogaine trials safely. What its screening, monitoring and staffing proposals mean for Canadian practitioners.

A clinician talks with a patient in a quiet hospital research room, illustrating hospital-based psychedelic research for chronic pain in Canada.
Industry

Psychedelic Research in Canada Turns to Pain Care: $2M for Hamilton Trials

Few pain patients discuss psychedelics with clinicians. $2M for Hamilton trials shows where psychedelic research in Canada is heading.

Line illustration of a human head in profile with fading upward arrows approaching a highlighted brain region, representing reduced bottom-up signalling into the default mode network.
Industry

Three Psychedelics, One Shared Brain Signature: What a New Stanford Study Means for Practitioners

A Stanford-led PNAS study finds MDMA, psilocybin and LSD each quiet bottom-up signalling into the default mode network. What it means for practitioners.

Linear timeline infographic in deep green and dark blue showing the DEA's 2022 withdrawn tryptamine proposal, its September 2026 re-proposal, and the October 2026 comment deadline.
Industry

The DEA Wants Five Psychedelic Tryptamines in Schedule I Again. Here Is Why Canadian Practitioners Should Follow the Fight

The US DEA has re-proposed Schedule I status for five psychedelic tryptamines, one in late-stage trials. What it means for Canadian practitioners.

A nurse sits with a patient in a quiet clinical room, illustrating supervised psilocybin-assisted therapy in a Canadian trial setting.
Industry

Health Canada Authorizes a 200-Participant Psilocybin Trial as Regulators Focus on Practitioner Training

Health Canada has authorized a 200-participant Phase 2 psilocybin trial for depression. What it means for Canadian practitioners and psychedelic therapy training.

Pink-and-white medicine capsules, some with small drawn faces, scattered on a light background.
Industry

New Zealand Approves MDMA for PTSD: What It Means for Canada

New Zealand has become the second country to approve MDMA for severe PTSD. What the approval actually says, and what it does and does not change for Canadian patients.

Abstract dawn light over open water, suggesting a threshold between night and morning.
Industry

The Psychedelics Gold Rush Meets Canadian Reality

Billionaire capital and a new federal report are pushing psychedelic therapy into the mainstream. A Canadian, patient-first view on what that money can and cannot buy.

Sunset over a prairie river in Saskatchewan, clouds mirrored in the still water.
Industry

The Medicine Was Not the Point

ATMA CENA co-founder Reverdi Darda reflects on a ceremony at the World Intertribal Summit, and what it teaches about how we truly hold space in this work.

The Gap and the Bridge — ATMA CENA webinar on Canadian psychedelic legislation
Industry

Canada Psilocybin Access: Two New Bills That Could Change Everything

Bill C-265 and Bill C-286 could make legal psilocybin access easier for Canadian patients. Here's what each proposes — and why we're paying attention.

Industry

ATMA and Cena Life Launch The Nationwide Psychedelic-assisted Therapy Healthcare Network

The initial launch of 10+ network clinics aims to support practitioners in private practice to successfully provide safe and effective psychedelic-assisted therapy (PaT) CALGARY, December 5, 2023 – ATMA Journey Centers Inc. (“ATMA”) and Cena Life, forefront leaders in advancing psychedelic-assisted therapy (PaT) are pleased to announce the opening of a licensed Calgary Clinic and the establishment of the Psychedelic-Assisted Therapy Healthcare Network, a national clinical network …

Industry

ATMA CENA Celebrates Groundbreaking Support from Alberta Blue Cross for Psychedelic Assisted Therapies

CALGARY, March 19, 2024 – A revolutionary step in mental health care is now underway through the collaboration between ATMA Journey Centers Inc. (“ATMA”), Cena Life Inc., and other partners across Canada, collectively known as ATMA CENA Psychedelic Healthcare Solutions (PHS). This collaborative is thrilled to announce a landmark move by Alberta Blue Cross to begin covering …

Psychedelic-assisted Therapy Clinic in Calgary
Industry

ATMA CENA Psychedelic Healthcare Solutions Opens Psychedelic-assisted Therapy Clinic in Calgary and Provides Update of Its Clinic Network

CALGARY, March 14, 2024 – ATMA CENA Psychedelic Healthcare Solutions (PHS) is a collaboration of ATMA Journey Centers Inc. (“ATMA”), Cena Life Inc. and partners across Canada to advance and expand access of psychedelic-assisted therapy (PaT) through the establishment of a clinic network. ATMA CENA PHS is pleased to announce commencement of the Calgary Clinic operations and its new location …

Navigating the Journey: What to Expect from Psychedelic Therapy in 2025
Industry

Navigating the Journey: What to Expect from Psychedelic Therapy in 2025

As we step into 2025, the conversation around mental health continues to evolve, and psychedelic therapy is increasingly recognized as an effective approach to healing. With a growing body of research supporting its efficacy for various mental health conditions, many individuals are considering this new-age treatment. If you’re curious about what to expect from psychedelic …

Celebrating Bicycle Day: Honoring Albert Hofmann and the Revival of LSD
Industry

Celebrating Bicycle Day: Honouring Albert Hofmann and the Revival of LSD

April 19 marks Bicycle Day, a celebration of the day in 1943 when Swiss chemist Albert Hofmann first intentionally ingested LSD (lysergic acid diethylamide). This date holds historical significance not only for the discovery of one of the most influential psychedelics but also for the ongoing resurgence of interest in psychedelics for therapeutic purposes. …

Bicycle Day and Integration Circles at ATMA CENA
For Clients

Bicycle Day and the Journey That Never Really Ends

Every April 19th, those of us in the world of psychedelics pause to mark a special moment in history. We call it Bicycle Day — and if you haven’t heard the story, it’s one worth knowing. On this day in 1943, Swiss chemist Albert Hofmann became the first person to intentionally experience LSD. After absorbing …

Psychedelic Therapy in Canada: What You Need to Know About Its Legal Status
Industry

Psychedelic Therapy in Canada: What You Need to Know About Its Legal Status

If you’ve been curious about psychedelic therapy but uncertain whether it’s actually legal, you’re not alone — and the good news is that the picture is far more encouraging than many people realize. Here’s the straightforward answer: yes, psychedelic therapy can be accessed legally in Canada. There are specific, regulated pathways that Health Canada has …

The Truth Thread in Nine Perfect Strangers and Why Safe, Ethical Care Matters
Industry

The Truth Thread in Nine Perfect Strangers and Why Safe, Ethical Care Matters

If you’ve seen Nine Perfect Strangers, you know the premise: nine guests arrive at a luxurious, exotic wellness retreat, hoping to change their lives. They’re promised deep transformation through a mysterious blend of treatments, including psychedelic therapy. As entertaining as the show is, it threads a real truth through its drama: people today are seeking more …

New Psychedelic Assisted Therapy Opportunities for Therapists
Industry

Regulatory Changes in Colorado Lead to New Psychedelic Assisted Therapy Opportunities for Therapists

The world of mental health treatment is rapidly evolving, particularly with the recent developments in Colorado regarding psychedelic-assisted therapy. As therapists, it’s crucial to stay informed about these changes and explore how they can enhance your practice. Colorado is paving the way for licensed psychedelic therapy in the U.S., opening the door for innovative treatment …

All You Need to Know from Oprah’s Podcast with Micheal Pollan- Can Psychedelics Heal Mental Trauma?
Industry

All You Need to Know from Oprah’s Podcast with Micheal Pollan- Can Psychedelics Heal Mental Trauma?

In a recent episode of Oprah’s podcast, she engages in discussion with Michael Pollan, the acclaimed author known for his insightful explorations of food, nature, and consciousness. Their conversation surrounds the healing potential of psychedelics for mental trauma, shedding light on how these substances are reshaping our understanding of mental health. The Cultural Shift Around Psychedelics …

Naturopathic vs. Western Medicine
Industry

Naturopathic vs. Western Medicine: Uncovering the Best Path to Health

In the realm of healthcare, the discussion surrounding naturopathic medicine and Western medicine often reveals a deep divide. While Western medicine has become the dominant approach in North America, naturopathy offers a holistic alternative that has been practiced for centuries. Understanding both systems can empower individuals to make informed choices about their health and wellness. …

The Role of Psychedelics in Healing Our Connection to Nature
Industry

The Role of Psychedelics in Healing Our Connection to Nature

In a world where we live so disconnected from nature, the ancient concept of the Anima Mundi—the soul of the world—offers a true solution in healing our relationship with the earth. Psychedelics often bring people to a newfound sense of connection – to themselves, to others, and to the earth. This connection invites us to …

Discover how ketamine therapy fast alleviates depression, anxiety & PTSD, unlocking deep healing while offering a potent alternative to traditional therapy!
Industry

Psychedelic Therapy vs Traditional Therapy: Unlocking A Healing Path

Psychedelic Therapy is becoming more widely understood and accepted as a highly effective treatment for depression, anxiety, PTSD, and other mental health concerns that have been resistant to traditional therapies. When exploring the question, is psychedelic therapy better than traditional therapy, there are many aspects to consider. Healing is a personal journey and should be …

Boost Your Mental Health This Valentine's Day: The Power of Self-Love
Industry

Boost Your Mental Health This Valentine’s Day: The Power of Self-Love

With Valentine’s Day right around the corner, you may be feeling the excitement of spending time with your significant other or the dread of feeling perpetually single on the day of love. Either way, both excitement and dread can lead to a day filled with disappointments and self-deprecation. Often our expectations have a way of …

gratitude, new year, resolutions, buddhism, therapy, happiness
Industry

Harnessing the Power of Gratitude: A New Year’s Approach to Happiness

With the new year upon us, it is natural to reflect on the past year and start to make new goals for the year to come. Oftentimes, new years resolutions consist of physical goals. This year we encourage you to focus more on your mental health goals. The truth is, if you don’t feel good …

family, peace, holidays
Industry

Ways to Keep Your Peace during Family Time over the Holidays

With the holidays right around the corner, you may be excited or nervous about what this means in terms of the copious amount of time spent with family. No matter which family you belong to, there tends to be something difficult about going back to your family home, or a new family home, maybe even …

The healing potential of psychedelics
Industry

The Healing Potential of Psychedelics

Building Systems of Trust At ATMA CENA, we understand that conversations around psychedelics as healing modalities are evolving, especially with regard to the legal landscape. Psychedelics have been shown to offer immense benefits for mental health well-being, spiritual growth, and personal reflection. We are dedicated to supporting the safe, responsible access and use of psychedelics …

rTMS Awareness
Industry

Raising Awareness, Funding, and Education for rTMS Treatment

Mental health treatments are evolving an new options are accessible for people who haven’t had success with traditional therapies. One such option is Repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive, community clinic procedure with a strong safety profile and growing clinical evidence for treating conditions like depression, pain and anxiety. Despite its success, rTMS remains …

Industry

The Importance of Integration in Psychedelic-Assisted Therapy

Did You Go to a Retreat? … Are You Confused? Attending a psychedelic retreat can be an exhilarating experience. Of course, most people (especially in North America) love traveling to exotic locations like Mexico, Costa Rica, or Peru; pair that with the hope of finding profound healing and enlightenment through Ayahuasca, Ibogaine, or other powerful …